Capstone Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,742
| Closed | -$165K | – | 867 |
|
|
2024
Q2 | $165K | Buy |
+26,742
| New | +$165K | ﹤0.01% | 934 |
|
|
2024
Q1 | – | Sell |
-18,650
| Closed | -$112K | – | 1336 |
|
|
2023
Q4 | $112K | Buy |
+18,650
| New | +$112K | ﹤0.01% | 953 |
|
|
2023
Q3 | – | Sell |
-17,164
| Closed | -$121K | – | 1107 |
|
|
2023
Q2 | $121K | Buy |
+17,164
| New | +$121K | ﹤0.01% | 759 |
|